Trilipix and Breastfeeding
Although no studies have been conducted on breastfeeding while taking Trilipix (fenofibric acid), based on the drug's chemical structure, it is believed to pass through breast milk. Nursing mothers are generally advised to avoid this medication. Before starting treatment with Trilipix, nursing women should talk to their healthcare providers about the potential risks.
It is unknown if Trilipix™ (fenofibric acid delayed-release, also known as choline fibrate) is safe for use during breastfeeding. Currently, breastfeeding women should avoid taking Trilipix. Therefore, you should talk with your healthcare provider before taking this medication if you are breastfeeding or plan to start.
No research has been done to see if Trilipix passes through breast milk. However, based on its chemical structure, the medication probably does pass through breast milk. The main concern about using Trilipix while breastfeeding is that similar medications have been shown to be possible carcinogens in rats. It is not a good idea to expose a developing infant to a possible carcinogen.
Trilipix can be used to treat either high cholesterol or high triglycerides. The effects of high cholesterol do not cause problems for many years, or even decades. Therefore, if a woman does not take cholesterol medicine while breastfeeding, it likely will have little impact on any long-term risks. However, the effects of high triglycerides can cause immediate problems, and you may need to be treated for this condition, even if this means you must stop breastfeeding.
Talking With Your Healthcare ProviderYou should talk with your healthcare provider about breastfeeding while taking Trilipix. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.